表紙
市場調査レポート

世界の分子診断市場の分析

Global Molecular Diagnostics Market Report: 2015 Edition

発行 Koncept Analytics 商品コード 248316
出版日 ページ情報 英文 48 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
世界の分子診断市場の分析 Global Molecular Diagnostics Market Report: 2015 Edition
出版日: 2015年06月15日 ページ情報: 英文 48 Pages
概要

当レポートでは、世界の分子診断市場について調査分析し、市場全体/セグメント別の分析、産業の動向、成長促進要因と課題、主要企業プロファイルを提供し、市場の見通しなども含めてお届けいたします。

第1章 診断:概要

  • 体外診断(IVD)
  • 分子診断

第2章 診断市場

  • 世界のIVD市場
    • 市場価格
    • 市場セグメント
  • 世界の分子診断市場
    • 市場価格
    • 市場セグメント
  • ヒト・パピローマウイルス (HPV)
    • 世界市場価格
    • 世界市場販売額
  • CT/NG市場
    • 世界市場価格
    • 世界市場販売額
  • 世界の遺伝子検査市場
    • 世界市場価格

第3章 市場動態

  • 産業の動向と発展
    • 次世代シーケンシング技術の成長
    • ポイントオブケア(POC)診断の普及
    • 非侵襲性胎児検診
  • 成長促進要因
    • 慢性疾患および感染性疾患罹患率の上昇
    • 技術発展
    • オーダーメイド医療に対する認識と受容の高まり
    • 経済成長
    • 新興国における拡大
    • 世界的な高齢人口の増加
    • 医療費の上昇
  • 課題
    • 遺伝子診断方法の課題
    • 厳しい規制

第4章 競合情勢

  • 分子診断の市場シェア
  • CT/NGの市場シェア
  • ヒト・パピローマウイルス (HPV)の市場シェア

第5章 企業プロファイル

  • Roche Holdings AG
    • 事業概要
    • 財務概要
    • 事業戦略
  • Qiagen NV
  • Abbott Laboratories
  • Novartis

第6章 市場の見通し

  • 市場予測
  • 予測手法

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Molecular diagnostics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are revolutionizing health care. Molecular diagnostics detects and measures the presence of genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling clinicians to tailor care at an individual level facilitating the practice of personalized medicine.

Molecular diagnostics today is routinely used in hospitals, reference labs, and blood banks. In the latter, molecular tests are used to screen donated blood products for infectious diseases like hepatitis and HIV. In hospitals, testing is often performed to identify pathogens in patients with infections. In fact, infectious diseases are one of the strongest growing areas within the molecular diagnostics field. There is also increasing demand for such technologies at the point of care.

The report “Global Molecular Diagnostics Market” provides an in-depth analysis of the molecular diagnostics market along with a detailed study of its various segments. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, Roche Holding AG, Qiagen NV, Abbott Laboratories and Novartis are being profiled.

The key factors driving the growth of the molecular diagnostics industry are rising incidence of chronic and infectious disease, rising awareness and acceptance of personalized medicine, expansion in emerging countries, ageing population and technological developments. Some of the noteworthy trend and developments of this industry are growth of next generation sequencing and growth in point of care diagnostics. However, the expansion of global molecular diagnostics industry is hindered by challenges in genetic diagnostics and regulatory issues.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table of Contents

1. Diagnostics: An Overview

  • 1.1. In Vitro Diagnostics
  • 1.2. Molecular Diagnostics

2. Diagnostics Market

  • 2.1. Global In Vitro Diagnostics (IVD) Market
    • Market Value
    • Market Segmentation
  • 2.2. Global Molecular Diagnostics Market
    • Market Value
    • Market Segmentation
    • 2.2.1. Human Papilloma Virus (HPV)
      • Global Market Value
      • Global Market Volume
    • 2.2.2. CT/NG
      • Global Market Value
      • Global Market Volume
    • 2.2.3. Global Genetic Testing Market
      • Global Market Value

3. Market Dynamics

  • 3.1. Industry Trends and Developments
    • 3.1.1. Growth of Next Generation Sequencing (NGS)
    • 3.1.2. Growth in Point-of-Care Diagnostics
    • 3.1.3. Growth in Non-Invasive Prenatal Testing (NIPT)
  • 3.2. Growth Drivers
    • 3.2.1. Rising Incidence of Chronic and Infectious Diseases
    • 3.2.2. Technological Developments
    • 3.2.3. Rising Awareness and Acceptance of Personalized Medicine
    • 3.2.4. Economic Growth
    • 3.2.5. Expansion in Emerging Countries
    • 3.2.6. Ageing Population Worldwide
    • 3.2.7. Rising Healthcare Expenditure
  • 3.3. Issues and Challenges
    • 3.3.1. Challenges in Genetic Diagnostics
    • 3.3.2. Regulatory Issues

4. Competitive Landscape

  • Molecular Diagnostics Market Share
  • CT/NG Market Share
  • HPV Market Share

5. Company Profiles

  • 5.1. Roche Holding AG
    • 5.1.1. Business Overview
    • 5.1.2. Financial Overview
    • 5.1.3. Business Strategies
  • 5.2. Qiagen NV
    • 5.2.1. Business Overview
    • 5.2.2. Financial Overview
    • 5.2.3. Business Strategies
  • 5.3. Abbott Laboratories
    • 5.3.1. Business Overview
    • 5.3.2. Financial Overview
    • 5.3.3. Business Strategies
  • 5.4. Novartis
    • 5.4.1. Business Overview
    • 5.4.2. Financial Overview
    • 5.4.3. Business Strategies

6. Market Outlook

  • 6.1. Market Forecast
  • 6.2. Forecast Methodology
    • 6.2.1. Dependent and Independent Variables
    • 6.2.2. Correlation Analysis
    • 6.2.3. Regression Analysis

List of Charts

  • IVD Market - Segments by Technology
  • Molecular Diagnostics - Traditional Process
  • Main Purposes of Molecular Diagnostics
  • IVD Market by Product Segments (2014)
  • Global IVD Market (2011-2016E)
  • Global IVD Market Share by Segment (2014)
  • Global Molecular Diagnostics Market (2009-2014)
  • Molecular Diagnostics Market Share by Segment (2014)
  • Molecular Diagnostics Market Share by Test Type (2014)
  • Global HPV Market by Value (2010-2014)
  • Global HPV Market by Volume (2010-2014)
  • Global CT/NG Market by Value (2011-2015E)
  • Global CT/NG Market by Volume (2011-2015E)
  • Global Genetic Testing Market (2007-2014)
  • Global GDP (2006-2013)
  • Global Ageing Population (2006-2014)
  • Global Healthcare Spending (2005-2014)
  • Global Molecular Diagnostic Market Share by Company (2014)
  • Global IVD Market Share by Company (2014E)
  • Global CT/NG Market Share by Company (2014)
  • Global HPV Market Share by Company (2014)
  • Roche's Revenues by Business Segments (2014)
  • Share of Diagnostics' Revenues by Sub-Segments, Roche (2014)
  • Roche's Net Sales and Net Income (2010-2014)
  • Qiagen's Revenue Share by Customer Classes Served (2014)
  • Qiagen's Revenue Share by Region (2014)
  • Qiagen's Net Sales and Net Income (2010-2014)
  • Abbott Laboratories Revenue Share by Segments (2014)
  • Abbott Laboratories Revenue and Net Income (2010-2014)
  • Novartis' Revenue Share by Business Segments (2014)
  • Novartis' Net Sales and Net Income (2010-2014)
  • Global Molecular Diagnostics Market Forecast (2014-2018E)

List of Tables

  • Financial Comparison of Key Players (2014)
  • Dependent & Independent Variables (2009-2014)
  • Correlation Matrix
  • Model Summary - Coefficient of Determination
  • Regression Coefficients Output
Back to Top